Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Prostate Cancer Origin: how does cancer spread?
Prostate Cancer Origin: How Does Cancer Spread? 4

Prostate cancer is a big problem for men in the United States. Every year, over 190,000 new cases are found.

The prostate gland is small, like a walnut. It’s very important for men’s health. Understanding prostate cancer is key to treating it well.

Prostate cancer usually starts in the prostate gland. But how it spreads can be different for everyone. It’s important for men to know the signs and how prostate cancer grows.

Key Takeaways

  • Prostate cancer is a significant health concern among men.
  • The prostate gland is important for men’s health.
  • Knowing how prostate cancer grows is vital.
  • How prostate cancer spreads can vary a lot.
  • It’s important for men to know the signs of prostate cancer.

Understanding the prostate gland anatomy

Prostate Cancer Origin: how does cancer spread?
Prostate Cancer Origin: How Does Cancer Spread? 5

The prostate gland is below the bladder and around the urethra. It’s key to male health. Knowing its anatomy helps us understand prostate problems.

This gland is about the size of a walnut. It’s in the pelvis, below the bladder and in front of the rectum. It wraps around the urethra, which carries urine out of the body.

Location and function of the prostate

The prostate is below the bladder and in front of the rectum. It surrounds the urethra. Its main job is to make seminal fluid, which helps sperm during ejaculation.

This fluid is full of enzymes, proteins, and nutrients. These are vital for sperm health.

Zones of the prostate gland

The prostate gland has several zones. Each has its own features. The peripheral zone is where most prostate cancers start. The transition zone is around the urethra and is where BPH often happens.

ZoneLocationFunction/Significance
Peripheral ZoneOuter part of the prostateMost common site for prostate cancer
Transition ZoneSurrounds the urethraTypically where BPH occurs
Central ZoneSurrounds the ejaculatory ductsLess commonly associated with prostate cancer

The prostate gland’s anatomy is complex. Different zones have different roles and meanings. Knowing this is key to diagnosing and treating prostate issues.

The cellular origins of prostate cancer

Prostate Cancer Origin: how does cancer spread?
Prostate Cancer Origin: How Does Cancer Spread? 6

Prostate cancer usually starts in the glandular cells that make prostate fluid. These cells are in the epithelial layer of the prostate gland. This layer has different cell types, each with its own role.

Types of Cells in the Prostate

The prostate gland mainly has epithelial and stromal cells. Epithelial cells make the glandular tissue and produce prostate-specific antigen (PSA). Stromal cells give the gland its structure.

Epithelial cells include basal, luminal, and neuroendocrine cells. Luminal cells are key because they are where adenocarcinomas, the most common type of prostate cancer, start.

Where Most Prostate Cancers Originate

Most prostate cancers are adenocarcinomas, coming from glandular epithelial cells. They usually begin in the peripheral zone of the prostate. This zone has most of the glandular tissue.

Cell TypeFunctionRelation to Prostate Cancer
Luminal CellsProduce PSA and other secretionsPrimary origin of adenocarcinomas
Basal CellsForm the basal layer of epitheliumLess commonly associated with cancer
Neuroendocrine CellsProduce neuroendocrine hormonesRarely associated with common prostate cancer types

Knowing where prostate cancer starts is key to making better treatments. By focusing on the specific cells involved, scientists can find new ways to fight cancer.

The peripheral zone: Primary site of prostate cancer

Prostate cancer often starts in the peripheral zone, a key area of the prostate gland. This zone is the outer part of the prostate. It’s important for understanding prostate cancer.

Why Most Prostate Cancers Start in the Peripheral Zone

The peripheral zone is where prostate cancer usually begins. This is because of its unique cells and how they change. Also, its location near other parts of the body might help cancer grow.

Knowing why prostate cancer often starts here is key. It helps doctors find better ways to diagnose and treat it. This could lead to better care for patients.

Detection Challenges and Opportunities

Finding prostate cancer in the peripheral zone is hard. Its location and shape make it tough to spot with old methods. But, new imaging like MRI is helping a lot.

Spotting cancer early is very important. It helps doctors treat it better. By understanding how to find cancer in this zone, doctors can improve care for patients.

How does cancer spread from the prostate?

The spread of prostate cancer involves local invasion, lymphatic spread, and vascular dissemination. Knowing these steps is key to finding effective treatments.

Local Invasion Mechanisms

Local invasion means cancer cells spread directly to nearby tissues and organs. This can happen in the seminal vesicles, bladder, and rectum. These areas are close to the prostate, making them more likely to be affected.

The process of local invasion is complex. Cancer cells interact with the surrounding stroma. They release growth factors and enzymes to help them move into nearby tissues.

Lymphatic and Vascular Spread

Prostate cancer can also spread through the lymphatic system and bloodstream. Lymphatic spread means cancer cells go to nearby lymph nodes. Vascular spread involves cancer cells traveling through the bloodstream to distant organs.

Spread MechanismDescriptionCommon Sites
Local InvasionDirect spread into surrounding tissuesSeminal vesicles, bladder, rectum
Lymphatic SpreadSpread through lymphatic vessels to lymph nodesRegional lymph nodes (e.g., pelvic lymph nodes)
Vascular SpreadDissemination through the bloodstreamBones, liver, lungs

It’s vital for doctors to understand how prostate cancer spreads. This knowledge helps them choose the best treatment for each patient.

Perineural invasion in prostate cancer

Perineural invasion is when cancer cells spread to the area around nerves. This happens in prostate cancer. It means cancer cells can use nerves to move further.

Defining Perineural Invasion

Perineural invasion is when cancer cells move into the space around nerves. This area is called the perineural space. It’s a way for cancer to spread beyond the first tumor.

This invasion is linked to more aggressive cancer and a higher chance of cancer coming back. Knowing about this is key for making good treatment plans.

Clinical Significance and Prognosis

The importance of perineural invasion is huge for understanding cancer and planning treatments. Research shows it raises the risk of cancer coming back after surgery.

Table: Clinical Implications of Perineural Invasion

Clinical FeatureSignificancePrognostic Implication
Perineural Invasion PresenceIndicates a chance for cancer to spread through nervesHigher risk of cancer coming back
Treatment PlanningMay need more intense or focused treatmentsCould lead to better results with the right treatment
PrognosisLinked to more aggressive cancerPoorer outlook without the right treatment

In summary, perineural invasion is a big deal in prostate cancer. It impacts both how likely cancer is to come back and how to treat it. Understanding and spotting perineural invasion helps in making better treatment plans for patients.

Common pathways of prostate cancer metastasis

Prostate cancer spreads through different routes, like the lymphatic and vascular systems. Knowing these paths helps predict how the disease will grow. It also guides treatment plans.

Lymph Node Involvement Patterns

Lymph nodes play a big role in prostate cancer spreading. Cancer cells first go to nearby lymph nodes. Then, they move to more distant places.

The first nodes to get cancer are in the pelvis. Studies have shown that the obturator and internal iliac nodes are often hit next.

Lymph Node GroupFrequency of Involvement
Pelvic Lymph NodesHigh
Obturator Lymph NodesModerate to High
Internal Iliac Lymph NodesModerate

Distant Metastasis Routes

When cancer moves past local lymph nodes, it can go to far-off places. Common spots include bones, the liver, and lungs.

Bone metastasis is a big problem in prostate cancer. Cancer cells often land in the spine, pelvis, and ribs. This can cause a lot of pain and even fractures.

“The skeleton is a common site for prostate cancer metastasis, and bone metastases are a major cause of morbidity in patients with advanced prostate cancer.”

The spread of prostate cancer is complex. It involves many factors. Understanding these paths is key to better treatments and outcomes for patients.

Where does prostate cancer spread first?

Prostate cancer usually goes to nearby lymph nodes first. Then, it spreads to other parts of the body. Knowing where it goes first helps doctors plan treatment and figure out the disease’s stage.

Regional lymph nodes as first sites

The lymphatic system is key in prostate cancer spread. Regional lymph nodes are the first places cancer cells go. These nodes catch cancer cells and other invaders.

When cancer reaches these nodes, it’s a big deal for figuring out the cancer’s stage and what the future might hold.

Here’s how cancer gets to these nodes:

  • Local invasion: Cancer cells move into nearby tissue.
  • Lymphatic spread: Cancer cells get into lymphatic vessels and go to regional lymph nodes.
  • Establishment of metastasis: Cancer cells start a new tumor in the lymph node.

Which lymph nodes does prostate cancer spread to first?

First, prostate cancer goes to the pelvic lymph nodes. These include:

  1. Obturator lymph nodes
  2. Internal iliac lymph nodes
  3. External iliac lymph nodes

Doctors check these nodes with imaging and surgery. Knowing which nodes are affected helps plan treatments like surgery and radiation.

In short, prostate cancer first goes to regional lymph nodes, mainly in the pelvis. Knowing this pattern is key to managing and treating the disease effectively.

Bone metastasis in prostate cancer

Bone metastasis is a common and serious issue with prostate cancer. When prostate cancer advances, it often spreads to the bones. This can greatly reduce a patient’s quality of life.

Why Prostate Cancer Commonly Spreads to Bones

Prostate cancer cells have a strong attraction to bones. This is due to several factors, including the bone environment and certain proteins that draw cancer cells.

The bone environment is perfect for prostate cancer cells to grow. This is because of growth factors and how cancer cells interact with bone cells.

Most Frequent Bone Metastasis Locations

Bone metastases from prostate cancer usually happen in the spine, pelvis, and ribs. These areas have a lot of red marrow. This makes them a good place for prostate cancer cells to grow.

LocationFrequency of Metastasis
SpineHigh
PelvisHigh
RibsModerate

Symptoms of Bone Metastasis

The symptoms of bone metastasis can vary. But pain is a common one. It can be very severe. Other symptoms include fractures, spinal cord compression, and high calcium levels.

“Bone pain is a common presenting symptom of bone metastasis in prostate cancer patients, significantly impacting their quality of life.”

Knowing the symptoms and where bone metastasis happens is key. It helps manage prostate cancer better and improves patient outcomes.

Other common sites of prostate cancer metastasis

Prostate cancer can spread to more than just bones. It can also affect other important organs. Knowing where it can go is key for taking care of patients.

Liver and Lung Involvement

The liver and lungs can also get affected by prostate cancer. Liver metastasis happens because of the liver’s blood flow. It can cause pain and jaundice. Lung metastasis is less common but can lead to coughing and breathing trouble.

Doctors have seen liver and lung metastases in prostate cancer patients. These happen when the disease is more advanced.

Brain Metastasis

Brain metastasis from prostate cancer is rare but serious. Symptoms include headaches, neurological problems, and seizures. It usually means the disease is in its late stages.

“The development of brain metastases in prostate cancer patients is a serious complication, requiring prompt and effective treatment,” said a leading oncologist.

Spread to Other Organs

Prostate cancer can also spread to other organs, like the adrenal glands, kidneys, and skin. This spread varies among people. It depends on the cancer’s genetics and the patient’s health.

Knowing prostate cancer can spread to different organs is vital. It shows why regular checks and specific treatments are so important.

Timeline: How long does it take for prostate cancer to spread?

Prostate cancer spreads at different rates for everyone. This depends on many factors. Knowing this timeline helps both patients and doctors plan the best treatment.

Factors Affecting the Rate of Spread

Many things can change how fast prostate cancer spreads. These include how aggressive the cancer is, its stage at diagnosis, the patient’s health, and the treatment plan. Aggressive prostate cancers grow and spread faster than less aggressive ones.

Genetic mutations also play a role. For example, mutations in TP53 or PTEN genes make the disease more aggressive. The level of prostate-specific antigen (PSA) and how it changes can also give clues about the cancer’s behavior.

Typical Progression Timelines

It’s hard to say exactly how long it will take for prostate cancer to spread. But, we can give general guidelines based on the cancer’s type. Slow-growing cancers might take years or even decades to spread beyond the prostate.

On the other hand, aggressive cancers can spread quickly, sometimes in just a few years after diagnosis. The table below shows typical timelines based on cancer aggressiveness.

Cancer AggressivenessTypical Time to MetastasisCommon Sites of Spread
Low-Grade10+ yearsLymph nodes, bones
Intermediate-Grade5-10 yearsLymph nodes, bones, lungs
High-Grade2-5 yearsBones, lymph nodes, liver, lungs

Knowing how prostate cancer spreads is key to managing it well. By looking at the factors that affect spread and understanding typical timelines, patients and doctors can make better treatment choices.

Gleason score and its relationship to cancer spread

Knowing the Gleason score is key to understanding prostate cancer’s severity and spread. It’s a system for grading cancer based on cell appearance under a microscope.

Understanding Gleason Grading

The Gleason grading system scores prostate cancer from 1 to 5. Grade 1 is the most differentiated, and Grade 5 is the least. The score is the sum of the two most common patterns, giving scores from 2 to 10.

Gleason Score Calculation: It’s found by adding the grades of the two most common cell patterns. For example, a score of 7 (3+4) means the most common pattern is Grade 3 and the second is Grade 4.

How Gleason Scores Predict Metastatic Potential

The Gleason score predicts prostate cancer’s aggressiveness. Higher scores mean more aggressive disease and a higher chance of cancer spreading. Research shows men with higher scores are more likely to see cancer spread.

Gleason ScoreCancer AggressivenessMetastatic Potential
2-6LowLow
7ModerateModerate
8-10HighHigh

Gleason 9 and High-Grade Cancer Outlook

Cancers with a Gleason score of 9 or 10 are high-grade and have a poor prognosis. They are more likely to spread and need aggressive treatment.

Prognosis for High-Grade Cancer: Patients with Gleason 9 or 10 prostate cancer often need hormone therapy, radiation, and chemotherapy. This combination helps manage the disease.

Detecting prostate cancer spread

Finding out if prostate cancer has spread early is key. It helps decide the best treatment and can improve survival chances.

Imaging Techniques for Identifying Metastasis

Imaging plays a big role in spotting cancer spread. Here are some methods:

  • CT Scans: Good for seeing if cancer has reached lymph nodes or distant areas.
  • MRI: Shows detailed pictures of the prostate and nearby areas, helping find local spread.
  • Bone Scans: Important for finding cancer in bones, a common place for it to spread.

Blood Tests and Biomarkers

Blood tests and biomarkers are also vital. They help find if cancer has spread. Key ones include:

  • PSA (Prostate-Specific Antigen): High levels might mean cancer has spread.
  • Other Biomarkers: Like PCA3 and TMPRSS2-ERG fusion, they help gauge metastasis risk.
BiomarkerSignificance
PSAElevated levels may indicate cancer spread
PCA3Assesses risk of prostate cancer and possible spread
TMPRSS2-ERG fusionLinked to aggressive prostate cancer

How to Tell if Prostate Cancer Has Spread

Figuring out if prostate cancer has spread involves imaging, blood tests, and doctor checks. Symptoms like bone pain, urinary problems, and general sickness can also hint at spread.

Spotting it early lets for quicker action. This can lead to better results for those with cancer that has spread.

Signs and symptoms that prostate cancer has spread

It’s important to know the signs of prostate cancer spreading. This helps us understand how the disease grows. When prostate cancer spreads, it can cause symptoms in different parts of the body.

Bone Pain and Fractures

Bones are a common place for prostate cancer to spread. Bone pain often happens in the back, hips, or ribs. This pain can last a long time and get worse.

In some cases, cancer can make bones weak. This can lead to fractures, even from small injuries.

The spine, pelvis, and ribs are often affected. Bone metastasis can also cause high calcium levels. This can lead to symptoms like nausea, confusion, and constipation.

Urinary and Systemic Symptoms

Prostate cancer spread can also cause urinary symptoms. But these symptoms are more common when the cancer is in the prostate. When the cancer spreads, it can cause weight loss, fatigue, and loss of appetite.

Metastasis to lymph nodes or other organs can cause swelling. This swelling can happen in the legs or other parts of the body.

Neurological Symptoms from Advanced Spread

In advanced cases, prostate cancer can reach the brain or spinal cord. This can cause headaches, seizures, or weakness in the limbs. Spinal cord compression is a serious issue that can cause pain, numbness, or trouble walking.

It’s vital to get medical help quickly for these symptoms. This can prevent further damage to the nervous system.

Knowing these signs and symptoms is key. It helps both patients and doctors manage the disease better. This improves the quality of life for those affected.

Treatment approaches for metastatic prostate cancer

Managing metastatic prostate cancer requires a variety of treatments. These aim to slow the disease’s growth and ease symptoms. The right treatment depends on how far the cancer has spread, the patient’s health, and other personal factors.

Hormone Therapy Options

Hormone therapy, or androgen deprivation therapy (ADT), is key in treating metastatic prostate cancer. It lowers male hormones that help cancer cells grow. There are different types of hormone therapy, including:

  • Luteinizing hormone-releasing hormone (LHRH) agonists and antagonists
  • Anti Androgens
  • Androgen synthesis inhibitors

The choice of hormone therapy depends on the cancer’s stage and the patient’s health. Combination therapies are often used to boost effectiveness.

Radiation and Chemotherapy

Radiation therapy can help relieve symptoms like pain from cancer spread to bones or other areas. Chemotherapy is used when cancer has spread beyond the prostate and hormone therapy no longer works.

Treatment ModalityPurposeCommon Applications
Radiation TherapyPalliative care, symptom reliefBone metastasis, localized pain
ChemotherapySystemic treatment, tumor controlCastration-resistant prostate cancer

Surgical Interventions

Surgical options, like robotic prostatectomy, are usually for localized prostate cancer. But for metastatic disease, surgery is not the main treatment. It might be considered to ease symptoms or improve quality of life in some cases.

The field of metastatic prostate cancer treatment is constantly changing. New therapies and treatment combinations are being researched. Patients should talk to their healthcare provider to find the best treatment plan for them.

Conclusion: Advancements in understanding and treating prostate cancer spread

Understanding how prostate cancer spreads is key to better treatments. Recent breakthroughs have greatly improved patient care. Research has revealed where prostate cancer starts, how it invades, and how it spreads.

The peripheral zone is where prostate cancer usually begins. Perineural invasion plays a big role in its spread. New imaging and biomarkers help find cancer early. This means treatments like hormone therapy, radiation, and chemotherapy can work better.

Research into prostate cancer’s biology and new treatments is ongoing. As we learn more, we can manage the disease better. This means patients can look forward to better outcomes and a better quality of life.

FAQ

Where does prostate cancer tend to metastasize to?

Prostate cancer often goes to nearby lymph nodes, bones, liver, and lungs. Bones are a common place, causing pain and fractures.

What is perineural invasion in prostate cancer?

Perineural invasion means cancer cells spread around nerves. It’s common in prostate cancer and affects treatment and prognosis.

How does prostate cancer spread?

It spreads through local invasion, lymphatic system to lymph nodes, or bloodstream to distant organs like bones, liver, or lungs.

What is the Gleason score, and how does it relate to cancer spread?

The Gleason score grades prostate cancer based on cell appearance. Higher scores mean more aggressive disease and a higher chance of spreading.

Where does prostate cancer spread first?

It usually goes to nearby lymph nodes first. Knowing which nodes are involved is key for treatment planning.

What are the symptoms of bone metastasis in prostate cancer?

Bone metastasis causes pain, fractures, and high calcium levels. These symptoms greatly affect quality of life.

Can prostate cancer spread to the brain?

Yes, though less common than bone metastasis, prostate cancer can reach the brain. Brain metastasis needs quick treatment.

How is prostate cancer spread detected?

Imaging like CT, MRI, and bone scans, along with blood tests and biomarkers, detect spread. Early detection is key.

What are the treatment approaches for metastatic prostate cancer?

Treatments include hormone therapy, radiation, chemotherapy, and surgery like robotic prostatectomy. Treatment depends on disease extent, patient health, and other factors.

What is the success rate of robotic prostatectomy?

Robotic prostatectomy’s success varies with surgeon experience and patient health. It’s a surgical option for removing the prostate gland.

How long does it take for prostate cancer to spread?

Spread time varies based on cancer aggressiveness, metastasis presence, and treatment success. Timelines differ among individuals.

Does prostate cancer metastasize to the liver?

Yes, though less common than bone metastasis, prostate cancer can reach the liver. Liver involvement signals advanced disease.

What happens when prostate cancer spreads to the lymph nodes?

Spread to lymph nodes means the disease has progressed. Knowing the extent of lymph node involvement is vital for treatment planning.

References

Moscatelli, D. (2010). PINing down the origin of prostate cancer. Cellular and Molecular Life Sciences, 67(15), 2553-2555. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641814

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91